BridgeBio Pharma, Inc.

BBIO

$81.50-1.74%

SEC Filings

Recommended10-Q · May 7, 2026

Not sure where to start? This is BridgeBio Pharma, Inc.'s most recent filing. Start with its AI summary.

Summarize this filing

10-QRecommendedMay 7, 2026

View on SEC EDGAR Generate Filing Summary

10-KFeb 24, 2026

View on SEC EDGAR Generate Filing Summary

10-QOct 29, 2025

View on SEC EDGAR Generate Filing Summary

10-QAug 5, 2025

View on SEC EDGAR Generate Filing Summary

10-QApr 29, 2025

View on SEC EDGAR Generate Filing Summary

10-KFeb 20, 2025

View on SEC EDGAR Generate Filing Summary

10-QNov 12, 2024

View on SEC EDGAR Generate Filing Summary

10-QAug 1, 2024

View on SEC EDGAR Generate Filing Summary

10-QMay 2, 2024

View on SEC EDGAR Generate Filing Summary

Showing filings since Aug 5, 2021. Full history on SEC EDGAR